Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825116 | Clinical Therapeutics | 2015 | 10 Pages |
Abstract
At 52 weeks of treatment, this analysis observed comparable CQM attainment for canagliflozin 100 mg, and superior CQM attainment for canagliflozin 300 mg, compared with sitagliptin 100 mg. ClinicalTrials.gov identifiers are NCT01106677 and NCT01137812.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Robert A. MD, Ujjwala PhD, Gary MD, Marcia F.T. PhD, Lawrence MD,